Analytical Data
-
基因名
dLK1
- Application
-
别名
dLK1；DLK；Protein delta homolog 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P80370
-
表达区间
24-297aa
-
氨基酸序列
AECFPACNPQNGFCEDDNVCRCQPGWQGPLCDQCVTSPGCLHGLCGEPGQ CICTDGWDGELCDRDVRACSSAPCANNGTCVSLDDGLYECSCAPGYSGKD CQKKDGPCVINGSPCQHGGTCVDDEGRASHASCLCPPGFSGNFCEIVANS CTPNPCENDGVCTDIGGDFRCRCPAGFIDKTCSRPVTNCASSPCQNGGTC LQHTQVSYECLCKPEFTGLTCVKKRALSPQQVTRLPNGYGLAYRLTPGVH ELPVQQPEHRILKVSMKELNKKTPVDHHHHHH
-
分子量
30 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
dLK1, a member of the leukemia inhibitory factor (LIF) family, has garnered significant interest in the field of molecular biology due to its role in various cellular processes, including cell proliferation, differentiation, and survival. Emerging research suggests that dLK1 plays a critical role in the maintenance of pluripotency in stem cells and has potential therapeutic implications in regenerative medicine and cancer treatment. The recombinant expression of dLK1 protein allows for the exploration of its biological functions and mechanisms of action in a controlled environment. Understanding the structure-function relationship of dLK1 can provide insights into its signaling pathways and interactions with other molecules. Moreover, recombinant dLK1 has the potential to be utilized in drug discovery and the development of novel therapeutic strategies. As the demand for innovative treatments increases, investigating dLK1's properties could pave the way for breakthroughs in tackling various diseases, including cancers and degenerative conditions. Thus, the study of dLK1 recombinant protein is positioned at the intersection of fundamental biology and applied biomedical research, making it a valuable target for future studies.
